Biogen Inc.
LSE: 0R1B.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Christopher A. Viehbacher
- Employees
- 7,605
- Headquarters
- Cambridge, United States
- IPO year
- 1991
- Market cap
- $28.4B
- Website
- https://www.biogen.com
Loading 0R1B…
Loading profile data…Frequently asked questions about 0R1B
What does Biogen Inc. (0R1B.L) do?
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees. The firm focuses on discovering, developing, manufacturing and delivering therap...
Where does 0R1B.L trade?
Biogen Inc. (0R1B.L) trades on the London Stock Exchange.
What sector is 0R1B.L in?
Biogen Inc. (0R1B.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Biogen Inc.?
Christopher A. Viehbacher is the chief executive officer of Biogen Inc. (0R1B.L).
Where is Biogen Inc. headquartered?
Biogen Inc. is headquartered in United States.
Does 0R1B.L pay a dividend?
Biogen Inc. (0R1B.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0R1B.L go public?
Biogen Inc. (0R1B.L) completed its initial public offering in 1991.